NEW YORK (GenomeWeb) – Pacific Biosciences said after the close of the market on Monday that it plans to sell shares of its common stock in a public offering.

The Menlo Park, California-based maker of sequencing platforms did not disclose the number of shares it planned to sell or how much money it expects to raise. The offering is pursuant to a $150 million shelf offering declared effective in August 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.